Dr. Christopher Pearson

Dr. Pearson received his Ph.D. from McGill University Cancer Centre studying DNA replication, then did a post-doctoral fellowship in the Texas Medical Center in Houston working on elucidating the mechanism of disease-causing repeat instability in Huntington’s disease, myotonic dystrophy, spinocerebellar ataxia, and fragile X mental retardation. In 1998 he was appointed at The Hospital for Sick Children Research Institute in the Program of Genetics & Genome Biology and was cross-appointed to the faculty at the University of Toronto in the Department of Medical Genetics, advancing to Senior Scientist and Associate Professor in 2004. In 1999 he was appointed as a Scholar of the Medical Research Council of Canada.  In 2001 he was appointed as a Scholar of the Canadian Genetic Disease Network, Canadian Network Centres of Excellence; awarded The Ontario Premier’s Research Excellence Award; and in 2006 received the International Opportunities Award, Canadian Institutes of Heath Research. He has been a Member of International Myotonic Dystrophy Consortium since inception in 1999.  He serves on advisory boards for the National Fragile X Foundation USA, National Ataxia Foundation USA, The Canadian Myotonic Dystrophy Registry, Prosensa Therapeutics, Valentia Biopharma, and has served as an ad hoc scientific advisor for The Marigold Foundation, TREAT-NMD, Cure Huntington’s Disease International, and the Fragile X Research Foundation Canada.  He has co-organized the International Conference on Unstable Microsatellites & Human Disease for the past five iterations, since 2004. He is an Associate Editor for PLoS Genetics, Journal of Medical Genetics, and Human Genetics. His laboratory studies the mechanisms of disease-causing repeat instability associated with neurological and neuromuscular disease, with the goal of developing effective treatment.

Dr. Christopher Pearson Grants